Research Article

Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult βENaC-Tg Mice

Figure 5

Pharmacological targeting of cathepsin S reduces airway inflammation in adult βENaC-Tg mice. Four-week-old WT and βENaC-Tg mice were treated daily with cathepsin S inhibitor VBY-999 (CatSi; 100 mg/kg) or dextrose vehicle control (veh) for 14 days. (a) Inhibition of cathepsin S in βENaC-Tg mice alters invariant chain (Ii) processing and results in the accumulation of the 10 kDa intermediate (p10), which was detected in lung lysate by Western blot ( per group). BAL fluid (b) total cell, (c) mononuclear, and (d) polymorphonuclear (PMN) cell counts were quantified ( mice per group). BAL fluid levels of (e) KC and (f) IL-13 were quantified by ELISA ( mice per group). ; (one-way ANOVA with Tukey’s multiple comparisons test).
(a)
(b)
(c)
(d)
(e)
(f)